Summary of the Clinical Problem Atherosclerotic cardiovascular disease (ASCVD) remains
the leading cause of death in the United States. Most individuals who develop ASCVD have …

The American Heart Association requests that this document be cited as follows: Arnett DK,
Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A …

Prevention of cardiovascular disease, undoubtedly an emphasis of clinical care in 2014, will
provide both opportunities and challenges to patients and their healthcare providers. The …

This review compares the primary prevention recommendations of the recent 2021
European Society of Cardiology (ESC) and 2019 American College of Cardiology …

ABSTRACT The American Society for Preventive Cardiology (ASPC)" Ten things to know
about ten cardiovascular disease risk factors–2022" is a summary document regarding …

The goals of the American College of Cardiology (ACC) and the American Heart Association
(AHA) are to prevent cardiovascular diseases (CVDs); improve the management of people …

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of
the American College of Cardiology/American Heart Association Task Force on Clinical …

Given rapid advancements in medical science, it is often challenging for the busy clinician to
remain up-to-date on the fundamental and multifaceted aspects of preventive cardiology and …

Background: Secondary prevention lifestyle and pharmacological treatment of
atherosclerotic cardiovascular disease (ASCVD) reduce a high proportion of recurrent …

Atherosclerotic cardiovascular disease (ASCVD) affects more than one-third of the adult
population, accounts for 35% of all US deaths, and is a leading cause of disability. ASCVD …